{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,11]],"date-time":"2026-10-11T07:16:50Z","timestamp":1791703010048,"version":"4.3.4"},"reference-count":27,"publisher":"American Academy of Pediatrics (AAP)","issue":"1","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2010,1,1]]},"abstract":"<jats:p>OBJECTIVES: Hereditary spherocytosis (HS) is the most common inherited hemolytic disease among people of Northern European decent. Neonates with HS can develop significant hyperbilirubinemia, but we suspect that HS is underrecognized as a cause of neonatal jaundice.<\/jats:p><jats:p>METHODS: We used electronic record repositories of Intermountain Healthcare to identify all neonates with a diagnosis of HS in a recent 5-year period. We compared these with the number of new HS cases anticipated on the basis of national prevalence and also with the number who had elevations in mean corpuscular hemoglobin concentration (MCHC), red cell distribution width (RDW), and bilirubin. We compared MCHC and RDW values of neonates who had direct antiglobulin test\u2013positive (DAT[+]) and DAT(\u2212) results and jaundice with values of neonates who had HS.<\/jats:p><jats:p>RESULTS: Eight neonates received a diagnosis of HS; however, we may have failed to diagnose 90% of cases. To assess whether some with a missed diagnosis of HS developed significant hyperbilirubinemia, we examined records of all 670 with a bilirubin level of \u226520 mg\/dL. Records of the 20 with the highest MCHC and RDW values suggested that HS was present but unrecognized in at least 7. Follow-up revealed a subsequent diagnosis of HS in 5; the other 2 are no longer in our health system. MCHC and RDW values were highest in those with HS, intermediate in the DAT(+) group, and lowest in the DAT(\u2212) group. An MCHC of \u226536.0 g\/dL had 82% sensitivity and 98% specificity for identifying HS.<\/jats:p><jats:p>CONCLUSION: We speculate that HS is underrecognized as a cause of neonatal hyperbilirubinemia. We speculate further that an MCHC of \u226536.0 g\/dL can alert caregivers to the possibility of HS.<\/jats:p>","DOI":"10.1542\/peds.2009-0864","type":"journal-article","created":{"date-parts":[[2009,12,1]],"date-time":"2009-12-01T01:35:22Z","timestamp":1259631322000},"page":"120-125","source":"Crossref","is-referenced-by-count":69,"title":["Hereditary Spherocytosis in Neonates With Hyperbilirubinemia"],"prefix":"10.1542","volume":"125","author":[{"given":"Robert D.","family":"Christensen","sequence":"first","affiliation":[{"name":"Department of Women and Newborns, Intermountain Healthcare, Salt Lake City, Utah"},{"name":"Division of Neonatology, McKay-Dee Hospital Center, Ogden, Utah"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Erick","family":"Henry","sequence":"additional","affiliation":[{"name":"Department of Women and Newborns, Intermountain Healthcare, Salt Lake City, Utah"},{"name":"Institute for Healthcare Delivery Research, Salt Lake City, Utah"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"417","published-online":{"date-parts":[[2010,1,1]]},"reference":[{"key":"2021120821221258100_R1","unstructured":"Gallager PG, Glader B. Hereditary spherocytosis, hereditary elliptocytosis, and other disorders associated with abnormalities of the erythrocyte membrane. In: Greer JP, Foerster J, Rodgers GM, et al, eds. Wintrobe's Clinical Hematology. 12th ed. Philadelphia, PA: Lippincott Williams & Wilkins; 2009:911\u2013920"},{"key":"2021120821221258100_R2","doi-asserted-by":"crossref","unstructured":"Perrotta S, Gallagher PG, Mohandas N. Hereditary spherocytosis. Lancet.\u20082008;372(9647):1411\u20131426","DOI":"10.1016\/S0140-6736(08)61588-3"},{"key":"2021120821221258100_R3","doi-asserted-by":"crossref","unstructured":"Berardi A, Lugli L, Ferrari F, et al. Kernicterus associated with hereditary spherocytosis and UGT1A1 promoter polymorphism. Biol Neonate.\u20082006;90(4):243\u2013246","DOI":"10.1159\/000093668"},{"key":"2021120821221258100_R4","doi-asserted-by":"crossref","unstructured":"Sgro M, Campbell D, Shah V. Incidence and causes of severe neonatal hyperbilirubinemia in Canada. CMAJ.\u20082006;175(6):587\u2013590","DOI":"10.1503\/cmaj.060328"},{"key":"2021120821221258100_R5","doi-asserted-by":"crossref","unstructured":"Michaels LA, Cohen AR, Zhao H, Raphael RI, Manno CS. Screening for hereditary spherocytosis by use of automated erythrocyte indexes. J Pediatr.\u20081997;130(6):957\u2013960","DOI":"10.1016\/S0022-3476(97)70283-X"},{"key":"2021120821221258100_R6","doi-asserted-by":"crossref","unstructured":"Akar N, Gokce H. Red blood cell indexes in patients with hereditary spherocytosis and beta-thalassemia combination. Pediatr Hematol Oncol.\u20082002;19(8):569\u2013573","DOI":"10.1080\/08880010290097431"},{"key":"2021120821221258100_R7","unstructured":"Eberie ES, Sciuccati G, Bonduel M, Diaz L, Staciuk R, Torres AF. Erythrocyte indexes in hereditary spherocytosis [in Spanish]. Medicina (B Aires).\u20082007;67(6 pt 2):698\u2013700"},{"key":"2021120821221258100_R8","doi-asserted-by":"crossref","unstructured":"Alter BP, Goldberg JD, Berkowitz RL. Red cell size heterogeneity during ontogeny. Am J Pediatr Hematol Oncol.\u20081988;10(4):279\u2013282","DOI":"10.1097\/00043426-198824000-00001"},{"key":"2021120821221258100_R9","doi-asserted-by":"crossref","unstructured":"Qurtom HA, al-Saleh QU, Lubani MM, et al. The value of red cell distribution width in the diagnosis of anaemia in children. Eur J Pediatr.\u20081989;148(8):745\u2013748","DOI":"10.1007\/BF00443100"},{"key":"2021120821221258100_R10","doi-asserted-by":"crossref","unstructured":"Eggert LD, Wiedmeier SE, Wilson J, Christensen RD. The effect of instituting a prehospital-discharge newborn bilirubin screening program in an 18-hospital health system. Pediatrics.\u20082006;117(5). Available at: www.pediatrics.org\/cgi\/content\/full\/117\/5\/e855","DOI":"10.1542\/peds.2005-1338"},{"key":"2021120821221258100_R11","doi-asserted-by":"crossref","unstructured":"Bhutani VK, Johnson L, Sivieri EM. Predictive ability of a predischarge hour-specific serum bilirubin for subsequent significant hyperbilirubinemia in healthy term and near-term newborns. Pediatrics.\u20081999;103(1):6\u201314","DOI":"10.1542\/peds.103.1.6"},{"key":"2021120821221258100_R12","doi-asserted-by":"crossref","unstructured":"Christensen RD, Jopling J, Henry E, Wiedmeier SE. The erythrocyte indices of neonates, defined using data from over 12,000 patients in a multihospital health care system. J Perinatol.\u20082008;28(1):24\u201328","DOI":"10.1038\/sj.jp.7211852"},{"key":"2021120821221258100_R13","doi-asserted-by":"crossref","unstructured":"Christensen RD, Henry E, Jopling J, Wiedmeier SE. The CBC: reference ranges for neonates. Semin Perinatol.\u20082009;33(1):3\u201311","DOI":"10.1053\/j.semperi.2008.10.010"},{"key":"2021120821221258100_R14","doi-asserted-by":"crossref","unstructured":"Johnson L, Bhutani VK, Karp K, Sivieri EM, Shapiro SM. Clinical report from the Pilot USA kernicterus registry (1991 to 2004). J Perinatol.\u20082009;29(suppl 1):S25\u2013S45","DOI":"10.1038\/jp.2008.211"},{"key":"2021120821221258100_R15","doi-asserted-by":"crossref","unstructured":"Bhutani VK, Johnson L. Synopsis report from the pilot USA kernicterus registry. J Perinatol.\u20082009;29(suppl 1):S4\u2013S7","DOI":"10.1038\/jp.2008.210"},{"key":"2021120821221258100_R16","doi-asserted-by":"crossref","unstructured":"Bhutani VK, Johnson L. A proposal to prevent severe neonatal hyperbilirubinemia and kernicterus. J Perinatol.\u20082009;29(suppl 1):S61\u2013S67","DOI":"10.1038\/jp.2008.213"},{"key":"2021120821221258100_R17","unstructured":"Stevenson DK, Wong RJ, Hintz SR, Vreman HJ. The jaundiced newborn: understanding and managing transitional hyperbilirubinemia[in Italian]. Minerva Pediatr.\u20082002;54(5):373\u2013382"},{"key":"2021120821221258100_R18","doi-asserted-by":"crossref","unstructured":"Stevenson DK, Wong RJ, DeSandre GH, Vreman HJ. A primer on neonatal jaundice. Adv Pediatr.\u20082004;51:263\u2013288","DOI":"10.1016\/S0065-3101(23)00042-7"},{"key":"2021120821221258100_R19","doi-asserted-by":"crossref","unstructured":"Saada V, Cynober T, Brossard Y, et al. Incidence of hereditary spherocytosis in a population of jaundiced neonates. Pediatr Hematol Oncol.\u20082006;23(5):387\u2013397","DOI":"10.1080\/08880010600646662"},{"key":"2021120821221258100_R20","doi-asserted-by":"crossref","unstructured":"Newman TB, Liljestrand P, Escobar GJ. Infants with bilirubin levels of 30 mg\/dL or more in a large managed care organization. Pediatrics.\u20082003;111(6 pt 1):1303\u20131311","DOI":"10.1542\/peds.111.6.1303"},{"key":"2021120821221258100_R21","doi-asserted-by":"crossref","unstructured":"Kaplan M, Hammerman C. The need for neonatal glucose-6-phosphate dehydrogenase screening: a global perspective. J Perinatol.\u20082009;29(suppl 1):S46\u2013S52","DOI":"10.1038\/jp.2008.216"},{"key":"2021120821221258100_R22","doi-asserted-by":"crossref","unstructured":"Kaplan M, Hammerman C. Glucose-6-phosphate dehydrogenase-deficient neonates: a potential cause for concern in North America. Pediatrics.\u20082000;106(6):1478\u20131479","DOI":"10.1542\/peds.106.6.1478"},{"key":"2021120821221258100_R23","doi-asserted-by":"crossref","unstructured":"Kaplan M, Hammerman C, Vreman HJ, Wong RJ, Stevenson DK. Severe hemolysis with normal blood count in a glucose-6-phosphate dehydrogenase deficient neonate. J Perinatol.\u20082008;28(4):306\u2013309","DOI":"10.1038\/sj.jp.7211919"},{"key":"2021120821221258100_R24","unstructured":"Wintrobe MM. A simple and accurate hematocrit. J Lab Clin Med.\u20081929;15:287\u2013296"},{"key":"2021120821221258100_R25","doi-asserted-by":"crossref","unstructured":"Zipursky A, Chinu C, Brown E, Brown EJ. The quantitation of spherocytes in ABO hemolytic disease. J Pediatr.\u20081979;94(6):965\u2013967","DOI":"10.1016\/S0022-3476(79)80236-X"},{"key":"2021120821221258100_R26","doi-asserted-by":"crossref","unstructured":"American Academy of Pediatrics Subcommittee on Hyperbilirubinemia. Management of hyperbilirubinemia in the newborn infant 35 or more weeks of gestation [published correction appears in Pediatrics. 2004;114(4):1138]. Pediatrics.\u20082004;114(1):297\u2013316","DOI":"10.1542\/peds.114.1.297"},{"key":"2021120821221258100_R27","doi-asserted-by":"crossref","unstructured":"Christensen RD, Eggert LD, Baer VL, Smith KN. Pyruvate kinase deficiency as a cause of extreme hyperbilirubinemia in neonates from a polygamist community. J Perinatol. 2010 (in press)","DOI":"10.1038\/jp.2009.118"}],"container-title":["Pediatrics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/publications.aap.org\/pediatrics\/article-pdf\/125\/1\/120\/1008856\/zpe00110000120.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/publications.aap.org\/pediatrics\/article-pdf\/125\/1\/120\/1008856\/zpe00110000120.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,3,17]],"date-time":"2024-03-17T22:35:52Z","timestamp":1710714952000},"score":1,"resource":{"primary":{"URL":"https:\/\/publications.aap.org\/pediatrics\/article\/125\/1\/120\/29778\/Hereditary-Spherocytosis-in-Neonates-With"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2010,1,1]]},"references-count":27,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2010,1,1]]},"published-print":{"date-parts":[[2010,1,1]]}},"URL":"https:\/\/doi.org\/10.1542\/peds.2009-0864","relation":{},"ISSN":["0031-4005","1098-4275"],"issn-type":[{"value":"0031-4005","type":"print"},{"value":"1098-4275","type":"electronic"}],"subject":[],"published":{"date-parts":[[2010,1,1]]}}}